Oprozomib

Overview

Oprozomib is a proteasome inhibitor that inhibits the activity of the proteasome by blocking the targeted protein breakdown normally performed by the proteasome leading to the induction of programmed cancer cell death.

SparkCures ID 63
Developed By Amgen
Generic Name Oprozomib
Additional Names ONX-0912
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.